may help
shrink tumors.

It's Tru. Keytruda.

KEYTRUDA does not work for everyone. Results may vary.

For certain patients
previously treated for
head and neck squamous
cell cancer

See Clinical Trial Results  See Clinical Trial Results 
KEYTRUDA® (pembrolizumab) Injection 100 mg

starting treatment
with keytruda

Learn More 

KEYTRUDA is the first immunotherapy approved by the FDA to help treat certain patients with head and neck squamous cell cancer (HNSCC).